Recursion Pharma , which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths in the colon in patients with a rare ...
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators. Please wait a minute before you try to comment again.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback